The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Pain Management Drugs Market Research Report 2025
Synopsis
The global Pet Pain Management Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 46%.
This report aims to provide a comprehensive presentation of the global market for Pet Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Pain Management Drugs.
Report Scope
The Pet Pain Management Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Pain Management Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Pain Management Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck Animal Health
Bayer
Vetoquinol
Norbrook Laboratories
Ceva Sante Animale
Dechra Pharmaceuticals
Chanelle
Segment by Type
NSAIDs
Opioids
Local Anesthetics
Alpha-2 Agonists
Disease-modifying Osteoarthritis Agents
Other Drugs
Segment by Application
Dogs
Cats
Horses
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Pain Management Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pet Pain Management Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 46%.
This report aims to provide a comprehensive presentation of the global market for Pet Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Pain Management Drugs.
Report Scope
The Pet Pain Management Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Pain Management Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Pain Management Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck Animal Health
Bayer
Vetoquinol
Norbrook Laboratories
Ceva Sante Animale
Dechra Pharmaceuticals
Chanelle
Segment by Type
NSAIDs
Opioids
Local Anesthetics
Alpha-2 Agonists
Disease-modifying Osteoarthritis Agents
Other Drugs
Segment by Application
Dogs
Cats
Horses
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Pain Management Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Pain Management Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NSAIDs
1.2.3 Opioids
1.2.4 Local Anesthetics
1.2.5 Alpha-2 Agonists
1.2.6 Disease-modifying Osteoarthritis Agents
1.2.7 Other Drugs
1.3 Market by Application
1.3.1 Global Pet Pain Management Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Horses
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Pain Management Drugs Market Perspective (2019-2030)
2.2 Pet Pain Management Drugs Growth Trends by Region
2.2.1 Global Pet Pain Management Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pet Pain Management Drugs Historic Market Size by Region (2019-2024)
2.2.3 Pet Pain Management Drugs Forecasted Market Size by Region (2025-2030)
2.3 Pet Pain Management Drugs Market Dynamics
2.3.1 Pet Pain Management Drugs Industry Trends
2.3.2 Pet Pain Management Drugs Market Drivers
2.3.3 Pet Pain Management Drugs Market Challenges
2.3.4 Pet Pain Management Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Pain Management Drugs Players by Revenue
3.1.1 Global Top Pet Pain Management Drugs Players by Revenue (2019-2024)
3.1.2 Global Pet Pain Management Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Pet Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Pain Management Drugs Revenue
3.4 Global Pet Pain Management Drugs Market Concentration Ratio
3.4.1 Global Pet Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Pain Management Drugs Revenue in 2023
3.5 Pet Pain Management Drugs Key Players Head office and Area Served
3.6 Key Players Pet Pain Management Drugs Product Solution and Service
3.7 Date of Enter into Pet Pain Management Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Pain Management Drugs Breakdown Data by Type
4.1 Global Pet Pain Management Drugs Historic Market Size by Type (2019-2024)
4.2 Global Pet Pain Management Drugs Forecasted Market Size by Type (2025-2030)
5 Pet Pain Management Drugs Breakdown Data by Application
5.1 Global Pet Pain Management Drugs Historic Market Size by Application (2019-2024)
5.2 Global Pet Pain Management Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pet Pain Management Drugs Market Size (2019-2030)
6.2 North America Pet Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pet Pain Management Drugs Market Size by Country (2019-2024)
6.4 North America Pet Pain Management Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Pain Management Drugs Market Size (2019-2030)
7.2 Europe Pet Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pet Pain Management Drugs Market Size by Country (2019-2024)
7.4 Europe Pet Pain Management Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Pain Management Drugs Market Size (2019-2030)
8.2 Asia-Pacific Pet Pain Management Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pet Pain Management Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Pet Pain Management Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Pain Management Drugs Market Size (2019-2030)
9.2 Latin America Pet Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pet Pain Management Drugs Market Size by Country (2019-2024)
9.4 Latin America Pet Pain Management Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Pain Management Drugs Market Size (2019-2030)
10.2 Middle East & Africa Pet Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pet Pain Management Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Pet Pain Management Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Pet Pain Management Drugs Introduction
11.1.4 Boehringer Ingelheim Revenue in Pet Pain Management Drugs Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Detail
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Pet Pain Management Drugs Introduction
11.2.4 Zoetis Revenue in Pet Pain Management Drugs Business (2019-2024)
11.2.5 Zoetis Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Detail
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Pet Pain Management Drugs Introduction
11.3.4 Merck Animal Health Revenue in Pet Pain Management Drugs Business (2019-2024)
11.3.5 Merck Animal Health Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Pet Pain Management Drugs Introduction
11.4.4 Bayer Revenue in Pet Pain Management Drugs Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Vetoquinol
11.5.1 Vetoquinol Company Detail
11.5.2 Vetoquinol Business Overview
11.5.3 Vetoquinol Pet Pain Management Drugs Introduction
11.5.4 Vetoquinol Revenue in Pet Pain Management Drugs Business (2019-2024)
11.5.5 Vetoquinol Recent Development
11.6 Norbrook Laboratories
11.6.1 Norbrook Laboratories Company Detail
11.6.2 Norbrook Laboratories Business Overview
11.6.3 Norbrook Laboratories Pet Pain Management Drugs Introduction
11.6.4 Norbrook Laboratories Revenue in Pet Pain Management Drugs Business (2019-2024)
11.6.5 Norbrook Laboratories Recent Development
11.7 Ceva Sante Animale
11.7.1 Ceva Sante Animale Company Detail
11.7.2 Ceva Sante Animale Business Overview
11.7.3 Ceva Sante Animale Pet Pain Management Drugs Introduction
11.7.4 Ceva Sante Animale Revenue in Pet Pain Management Drugs Business (2019-2024)
11.7.5 Ceva Sante Animale Recent Development
11.8 Dechra Pharmaceuticals
11.8.1 Dechra Pharmaceuticals Company Detail
11.8.2 Dechra Pharmaceuticals Business Overview
11.8.3 Dechra Pharmaceuticals Pet Pain Management Drugs Introduction
11.8.4 Dechra Pharmaceuticals Revenue in Pet Pain Management Drugs Business (2019-2024)
11.8.5 Dechra Pharmaceuticals Recent Development
11.9 Chanelle
11.9.1 Chanelle Company Detail
11.9.2 Chanelle Business Overview
11.9.3 Chanelle Pet Pain Management Drugs Introduction
11.9.4 Chanelle Revenue in Pet Pain Management Drugs Business (2019-2024)
11.9.5 Chanelle Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pet Pain Management Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of NSAIDs
Table 3. Key Players of Opioids
Table 4. Key Players of Local Anesthetics
Table 5. Key Players of Alpha-2 Agonists
Table 6. Key Players of Disease-modifying Osteoarthritis Agents
Table 7. Key Players of Other Drugs
Table 8. Global Pet Pain Management Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pet Pain Management Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Pet Pain Management Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Pet Pain Management Drugs Market Share by Region (2019-2024)
Table 12. Global Pet Pain Management Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Pet Pain Management Drugs Market Share by Region (2025-2030)
Table 14. Pet Pain Management Drugs Market Trends
Table 15. Pet Pain Management Drugs Market Drivers
Table 16. Pet Pain Management Drugs Market Challenges
Table 17. Pet Pain Management Drugs Market Restraints
Table 18. Global Pet Pain Management Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Pet Pain Management Drugs Market Share by Players (2019-2024)
Table 20. Global Top Pet Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Pain Management Drugs as of 2023)
Table 21. Ranking of Global Top Pet Pain Management Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Pet Pain Management Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pet Pain Management Drugs Product Solution and Service
Table 25. Date of Enter into Pet Pain Management Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pet Pain Management Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Pet Pain Management Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Pet Pain Management Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Pet Pain Management Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Pet Pain Management Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Pet Pain Management Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Pet Pain Management Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Pet Pain Management Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Pet Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Pet Pain Management Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Pet Pain Management Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Pet Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Pet Pain Management Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Pet Pain Management Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Pet Pain Management Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Pet Pain Management Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Pet Pain Management Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Pet Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Pet Pain Management Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Pet Pain Management Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Pet Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Pet Pain Management Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pet Pain Management Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Boehringer Ingelheim Company Detail
Table 51. Boehringer Ingelheim Business Overview
Table 52. Boehringer Ingelheim Pet Pain Management Drugs Product
Table 53. Boehringer Ingelheim Revenue in Pet Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 54. Boehringer Ingelheim Recent Development
Table 55. Zoetis Company Detail
Table 56. Zoetis Business Overview
Table 57. Zoetis Pet Pain Management Drugs Product
Table 58. Zoetis Revenue in Pet Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 59. Zoetis Recent Development
Table 60. Merck Animal Health Company Detail
Table 61. Merck Animal Health Business Overview
Table 62. Merck Animal Health Pet Pain Management Drugs Product
Table 63. Merck Animal Health Revenue in Pet Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 64. Merck Animal Health Recent Development
Table 65. Bayer Company Detail
Table 66. Bayer Business Overview
Table 67. Bayer Pet Pain Management Drugs Product
Table 68. Bayer Revenue in Pet Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 69. Bayer Recent Development
Table 70. Vetoquinol Company Detail
Table 71. Vetoquinol Business Overview
Table 72. Vetoquinol Pet Pain Management Drugs Product
Table 73. Vetoquinol Revenue in Pet Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 74. Vetoquinol Recent Development
Table 75. Norbrook Laboratories Company Detail
Table 76. Norbrook Laboratories Business Overview
Table 77. Norbrook Laboratories Pet Pain Management Drugs Product
Table 78. Norbrook Laboratories Revenue in Pet Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 79. Norbrook Laboratories Recent Development
Table 80. Ceva Sante Animale Company Detail
Table 81. Ceva Sante Animale Business Overview
Table 82. Ceva Sante Animale Pet Pain Management Drugs Product
Table 83. Ceva Sante Animale Revenue in Pet Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 84. Ceva Sante Animale Recent Development
Table 85. Dechra Pharmaceuticals Company Detail
Table 86. Dechra Pharmaceuticals Business Overview
Table 87. Dechra Pharmaceuticals Pet Pain Management Drugs Product
Table 88. Dechra Pharmaceuticals Revenue in Pet Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 89. Dechra Pharmaceuticals Recent Development
Table 90. Chanelle Company Detail
Table 91. Chanelle Business Overview
Table 92. Chanelle Pet Pain Management Drugs Product
Table 93. Chanelle Revenue in Pet Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 94. Chanelle Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Pain Management Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pet Pain Management Drugs Market Share by Type: 2023 VS 2030
Figure 3. NSAIDs Features
Figure 4. Opioids Features
Figure 5. Local Anesthetics Features
Figure 6. Alpha-2 Agonists Features
Figure 7. Disease-modifying Osteoarthritis Agents Features
Figure 8. Other Drugs Features
Figure 9. Global Pet Pain Management Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Pet Pain Management Drugs Market Share by Application: 2023 VS 2030
Figure 11. Dogs Case Studies
Figure 12. Cats Case Studies
Figure 13. Horses Case Studies
Figure 14. Other Case Studies
Figure 15. Pet Pain Management Drugs Report Years Considered
Figure 16. Global Pet Pain Management Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Pet Pain Management Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Pet Pain Management Drugs Market Share by Region: 2023 VS 2030
Figure 19. Global Pet Pain Management Drugs Market Share by Players in 2023
Figure 20. Global Top Pet Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Pain Management Drugs as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Pet Pain Management Drugs Revenue in 2023
Figure 22. North America Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Pet Pain Management Drugs Market Share by Country (2019-2030)
Figure 24. United States Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Pet Pain Management Drugs Market Share by Country (2019-2030)
Figure 28. Germany Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Pet Pain Management Drugs Market Share by Region (2019-2030)
Figure 36. China Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Pet Pain Management Drugs Market Share by Country (2019-2030)
Figure 44. Mexico Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Pet Pain Management Drugs Market Share by Country (2019-2030)
Figure 48. Turkey Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Pet Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Pet Pain Management Drugs Business (2019-2024)
Figure 51. Zoetis Revenue Growth Rate in Pet Pain Management Drugs Business (2019-2024)
Figure 52. Merck Animal Health Revenue Growth Rate in Pet Pain Management Drugs Business (2019-2024)
Figure 53. Bayer Revenue Growth Rate in Pet Pain Management Drugs Business (2019-2024)
Figure 54. Vetoquinol Revenue Growth Rate in Pet Pain Management Drugs Business (2019-2024)
Figure 55. Norbrook Laboratories Revenue Growth Rate in Pet Pain Management Drugs Business (2019-2024)
Figure 56. Ceva Sante Animale Revenue Growth Rate in Pet Pain Management Drugs Business (2019-2024)
Figure 57. Dechra Pharmaceuticals Revenue Growth Rate in Pet Pain Management Drugs Business (2019-2024)
Figure 58. Chanelle Revenue Growth Rate in Pet Pain Management Drugs Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
